This acquisition of the ASI product line expands Applied Spectra’s product portfolio into excimer laser ablation and helium thermochronology instrumentation.
Applied Spectra, Inc., of Freemont, California, has acquired the rights from Australian Scientific Instruments Pty Ltd (ASI) of Fyshwick, Australia) to manufacture, sell, and support RESOlution, Alphachron, and RESOchron Instruments. This acquisition of the ASI product line expands Applied Spectra’s product portfolio into excimer laser ablation (LA) and helium thermochronology instrumentation.
Service and technical support will continue to be provided from the expanded network of the current ASI product support team with the international support network that Applied Spectra has in place. ASI’s manufacturing operation for the acquired product lines will be moved to Applied Spectra’s headquarters in California.
“The acquired product lines greatly expand the laser technology options for our customers in delivering the best analytical performance and cost,” Jong H. Yoo, CEO and president of Applied Spectra, said in a statement. “The LA instrument line from Applied Spectra now encompasses solid state and excimer lasers utilizing nanosecond and femtosecond laser pulses.”
An Interview with AES Mid-Career Award Recipient Jason Dwyer
July 25th 2024Jason Dwyer of the University of Rhode Island has been named the recipient of the American Electrophoresis Society’s Mid-Career Award, which honors exceptional contributions to the field of electrophoresis, microfluidics, and related areas by an individual who is currently in the middle of their career.
Glucose's Impact on Brain Cancer Cells Unveiled Through Raman Imaging
July 25th 2024Researchers have used Raman spectroscopy and chemometric methods to reveal how glucose affects normal and cancerous brain cell metabolism. Their findings highlight specific biomarkers that can distinguish metabolic changes, potentially aiding in cancer research and treatment.